Legislation to remove CMS restrictions on anemia drugs

10/2/2007 | Hill, The

A Democrat and a Republican have introduced legislation in Congress that would overturn a July CMS decision to restrict reimbursements for erythropoiesis-stimulating drugs that treat anemia in cancer patients. The legislation says the CMS policy puts patients at risk by restricting access to the drugs, including Amgen's Epogen and Aranesp and Johnson & Johnson's Procrit.

View Full Article in:

Hill, The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ